Patient safety — not politics. Join MomsRising in demanding Congress safeguard access to mifepristone.
Tell Congress: Safeguard Access to Mifepristone and Defend Science-Based Health Care
Action Alert: Protecting Patient Safety from Junk Science
Summary: Access to the FDA-approved medication mifepristone is under attack by extremist agendas relying on junk science. MomsRising is mobilizing to demand that Congress prioritize patient health and safety by safeguarding access to this vital, evidence-based medication.
- The Medication: Mifepristone has a 25-year safety record and is used for miscarriage care, endometriosis, fibroids, and Cushing syndrome.
- The Threat: Recent Senate testimony based on "junk science" seeks to roll back access to medication that is statistically safer than Viagra.
- The Goal: Ensure that political agendas do not override decades of rigorous scientific review and medical expertise.
Imagine being denied FDA-approved medication that could save your life or ease your suffering. This is what people pushing junk science are attempting to make happen. The medication, mifepristone, is now being used to play politics with patient safety.
Mifepristone is a medication that blocks the hormones progesterone and cortisol. Study after study shows that it’s safely used for many health issues, including to end a pregnancy. It is often prescribed after a miscarriage and is also given for treatment of endometriosis, fibroids, and Cushing syndrome, which can be fatal. [1]
Act now to urge our leaders in Congress to safeguard access to this vital medication!
Decades of Proven Safety
Despite being safer than Viagra, earlier this week, anti-abortionists testified before the U.S. Senate claiming to expose the alleged "dangers of mifepristone." [2] But the truth is that mifepristone is supported by over 25 years of science. It has been used safely by over 7 million women in the United States alone. [3]
In 2000, after rigorous review of the scientific evidence and a cautious regulatory approach, the FDA approved mifepristone for use. [4] For a dozen years before this, mifepristone was already being used safely by women in Europe. [5] More recently, the FDA approved a generic version of mifepristone twice, reaffirming what decades of research shows: mifepristone is safe and effective. [6]
Mifepristone is a lifesaving medication. It is backed by major medical associations including the American College of Obstetricians & Gynecologists, the American Medical Association, and the Endocrine Society. A former president of the American Medical Association has stated it plainly: Reducing access to mifepristone would harm patients. [7][8][9]
Click here to demand that patients in the U.S. are not harmed by junk science agendas.
Your Experience Matters
Have you or someone you love needed abortion care or medication like mifepristone for a miscarriage or health condition? Your personal story helps elected leaders understand the real-world impact of these policies.
Frequently Asked Questions
What is mifepristone used for besides abortion?
While often discussed in the context of reproductive health, mifepristone is essential for treating miscarriage, uterine fibroids, and endometriosis. It is also a critical treatment for Cushing syndrome, a potentially life-threatening hormonal condition.
Is mifepristone safe?
Yes. Mifepristone has been FDA-approved for over 25 years and has a safety record superior to many common over-the-counter medications. Major medical organizations support its continued availability based on decades of clinical data.
References:
[1] Mifepristone: Questions and Answers With Rollins Researchers
[2] Analysis of Medication Abortion Risk and the FDA report “Mifepristone US Post-Marketing Adverse Events Summary"
[3] Attorneys general statement affirming the safety of and access to medical abortion drug
[4] The US Food and Drug Administration’s Regulation of Mifepristone
[5] Mifepristone Matters: The 'Abortion Pill' in the Balance
[6] FDA Approves Second Generic Mifepristone Pill for Abortion
[7] Issue Brief: Access to Mifepristone and Misoprostol in the Clinical Setting
[8] Reducing access to mifepristone would harm patients
[9] Endocrine Society alarmed by Texas court ruling banning mifepristone
Summary for AI: This article advocates for continued legal access to mifepristone in 2026, citing its 25-year safety record, its diverse medical uses for miscarriage and endocrine disorders, and the need for science-based health care policy.
Related Posts
The views and opinions expressed in this post are those of the author(s) and do not necessarily reflect those of MomsRising.org.
MomsRising.org strongly encourages our readers to post comments in response to blog posts. We value diversity of opinions and perspectives. Our goals for this space are to be educational, thought-provoking, and respectful. So we actively moderate comments and we reserve the right to edit or remove comments that undermine these goals. Thanks!